X
Newron faces delay to would-be schizophrenia blockbuster
https://pharmaphorum.com/news/newron-faces-delay-to-would-be-schizophrenia-blockbuster/
Newron
Newron to re-file Parkinson’s drug in US
Regulator drops demand for further clinical trials.
Regulator drops demand for further clinical trials.